4.7 Article

A Stepwise Framework for the Systematic Development of Lipid Nanoparticles

Journal

BIOMOLECULES
Volume 12, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/biom12020223

Keywords

drug formulation; lipid nanoparticles; multivariate analysis; NLCs; screening; SLNs

Funding

  1. Portuguese Foundation for Science and Technology (FCT)
  2. European Union
  3. QREN
  4. FEDER
  5. COMPETE
  6. PIDDAC
  7. iBiMED [UIDB/04501/2020, POCI-01-0145-FEDER-007628]
  8. Unidade de Investigacao Cardiovascular [UID/IC/00051/2019]
  9. LAQV-REQUIMTE [UIDB/50006/2020, CENTRO-01-0145-FEDER-03075]
  10. Coimbra Chemistry Center, CQC [UID/QUI/00313/2020]
  11. FCT [IF/00286/2015, SFRH/BD/149138/2019, SFRH/BD/133996/2017]
  12. Fundação para a Ciência e a Tecnologia [SFRH/BD/133996/2017, SFRH/BD/149138/2019] Funding Source: FCT

Ask authors/readers for more resources

This article presents a stepwise framework for nanoparticle production for disulfiram delivery. It involves analysis of drug in lipid solubility to select suitable liquid lipids, drug partitioning studies to determine solid lipids with increased capacity for solubilizing and entrapping disulfiram, and microscopic evaluation of physical compatibility between liquid and solid lipids to indicate promising core compositions. The impact of the outer surfactant layer on the colloidal properties of the nanosystems is evaluated using machine learning algorithms.
A properly designed nanosystem aims to deliver an optimized concentration of the active pharmaceutical ingredient (API) at the site of action, resulting in a therapeutic response with reduced adverse effects. Due to the vast availability of lipids and surfactants, producing stable lipid dispersions is a double-edged sword: on the one hand, the versatility of composition allows for a refined design and tuning of properties; on the other hand, the complexity of the materials and their physical interactions often result in laborious and time-consuming pre-formulation studies. However, how can they be tailored, and which premises are required for a right at first time development? Here, a stepwise framework encompassing the sequential stages of nanoparticle production for disulfiram delivery is presented. Drug in lipid solubility analysis leads to the selection of the most suitable liquid lipids. As for the solid lipid, drug partitioning studies point out the lipids with increased capacity for solubilizing and entrapping disulfiram. The microscopical evaluation of the physical compatibility between liquid and solid lipids further indicates the most promising core compositions. The impact of the outer surfactant layer on the colloidal properties of the nanosystems is evaluated recurring to machine learning algorithms, in particular, hierarchical clustering, principal component analysis, and partial least squares regression. Overall, this work represents a comprehensive systematic approach to nanoparticle formulation studies that serves as a basis for selecting the most suitable excipients that comprise solid lipid nanoparticles and nanostructured lipid carriers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available